retatrutide effects clinical trial Retatrutide—A Game Changer in Obesity Pharmacotherapy Triple hormone receptor agonist retatrutide

Hair shedding during weight loss is often due to a temporary shift in the hair growth cycle, sometimes referred to as telogen effluvium

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Perdomo CM, Cohen RV, Sumithran P, Clment K, Frhbeck G

The severity is typically less dramatic than the 0.25 to 0.5 mg jump because the body has already developed some tolerance to GLP-1 receptor activation

Registration Link: Click for Fully Insured Clinical Management Producer Portal Enrollment & eBill Demo Monday, August 29, 2022 @ 1:00 PM Description: The enGen team will be providing a demo of the enrollment and billing functions accessed through the producer portal

Important Safety Note: GLP-1 medications are strictly contraindicated (must not be used) if you have a personal or family history of Medullary Thyroid Cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)